Initiation of neuronal differentiation requires PI3-kinase/TOR signalling in the vertebrate neural tube

Developmental Biology

Volumn 338, Issue 2, 2010, Pages 215-225

  Fishwick, Katherine J ^a   Li, Roman A ^a   Halley, Pamela ^a   Deng, Peiyi ^a   Storey, Kate G ^a  

^a State Key Laboratory of Plant Physiology and Biochemistry   (United Kingdom)

Author keywords

Cell cycle; Chick; Mouse; Neuronal differentiation; PI3 kinase; Rapamycin; TOR; Tuberous sclerosis; Vertebrate neurogenesis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MAMMALIAN TARGET OF RAPAMYCIN; NEUROGENIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RAPAMYCIN; TRANSCRIPTION FACTOR SOX1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CHICK; CONTROLLED STUDY; EMBRYO; GENE REPRESSION; MOUSE; MOUSE MUTANT; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD; VERTEBRATE;

MUS; VERTEBRATA;

EID: 74749106584     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.12.001     Document Type: Article

References (56)

1. Allan G.J., Zannoni A., McKinnell I., Otto W.R., Holzenberger M., Flint D.J., and Patel K. Major components of the insulin-like growth factor axis are expressed early in chicken embryogenesis, with IGF binding protein (IGFBP)-5 expression subject to regulation by Sonic Hedgehog. Anat. Embryol. (Berl.) 207 (2003) 73-84
2. Arsenijevic Y., and Weiss S. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J. Neurosci 18 (1998) 2118-2128
3. Bain J., Plater L., Elliott M., Shpiro N., Hastie J., McLauchlan H., Klevernic I., Arthur S., Alessi D., and Cohen P. The selectivity of protein kinase inhibitors; a further update. Biochem. J. 408 (2007) 97-315
4. Balendran A., Currie R., Armstrong C.G., Avruch J., and Alessi D.R. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J. Biol. Chem 274 (1999) 37400-37406
5. Bateman J.M., and McNeill H. Temporal control of differentiation by the insulin receptor/Tor pathway in Drosophila. Cel 119 (2004) 87-96
6. Bateman J.M., and McNeill H. Insulin/IGF signalling in neurogenesis. Cell. Mol. Life Sci. 63 (2006) 1701-1705
7. Bel-Vialar S., Medevielle F., and Pituello F. The on/off of Pax6 controls the tempo of neuronal differentiation in the developing spinal cord. Dev. Biol. 305 (2007) 659-673
8. Bertrand N., Castro D.S., and Guillemot F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3 (2002) 517-530
9. Camarero G., Leon Y., Gorospe I., De Pablo F., Alsina B., Giraldez F., and Varela-Nieto I. Insulin-like growth factor 1 is required for survival of transit-amplifying neuroblasts and differentiation of otic neurons. Dev. Biol. 262 (2003) 242-253
10. Chapman S.C., Collignon J., Schoenwolf G.C., and Lumsden A. Improved method for chick whole-embryo culture using a filter paper carrier. Dev. Dyn. 220 (2001) 284-289
11. Conejo R., Valverde A.M., Benito M., and Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J. Cell. Physiol. 186 (2001) 82-94
12. Coolican S.A., Samuel D.S., Ewton D.Z., McWade F.J., and Florini J.R. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272 (1997) 6653-6662
13. Crino P.B., Nathanson K.L., and Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 355 (2006) 1345-1356
14. D'Ercole A.J., Ye P., and O'Kusky J.R. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36 (2002) 209-220
15. Diez del Corral R., Breitkreuz D.N., and Storey K.G. Onset of neuronal differentiation is regulated by paraxial mesoderm and requires attenuation of FGF signalling. Development 129 (2002) 1681-1691
16. Easton R.M., Cho H., Roovers K., Shineman D.W., Mizrahi M., Forman M.S., Lee V.M., Szabolcs M., de Jong R., Oltersdorf T., Ludwig T., Efstratiadis A., and Birnbaum M.J. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 25 (2005) 1869-1878
17. Erbay E., and Chen J. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 276 (2001) 36079-36082
18. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
19. Frade J.M. Interkinetic nuclear movement in the vertebrate neuroepithelium: encounters with an old acquaintance. Prog. Brain Res. 136 (2002) 67-71
20. Gingras A., Raught B., and Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15 (2007) 807-826
21. Hamburger H., and Hamilton H.L. A series of normal stages in the development of the chick embryo. J. Exp. Morphol. 88 (1951) 49-92
22. Hammerle B., Vera-Samper E., Speicher S., Arencibia R., Martinez S., and Tejedor F.J. Mnb/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions. Dev. Biol. 246 (2002) 259-273
23. Han J., Wang B., Xiao Z., Gao Y., Zhao Y., Zhang J., Chen B., Wang X., and Dai J. Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin. Mol. Cell. Neurosci. 39 (2008) 118-124
24. Hashemolhosseini S., Nagamine Y., Morley S.J., Desrivieres S., Mercep L., and Ferrari S. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem. 273 (1998) 14424-14429
25. Hentges K., Sirry B., Gingeras A.C., Sarbassov D., Sonenberg N., Sabatini D.M., and Peterson A. FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13796-13801
26. Hentges K., Thompson K., and Peterson A. The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development 126 (1999) 1601-1609
27. Hidalgo M., and Rowinsky E.K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19 (2000) 6680-6686
28. Hodge R.D., D'Ercole A.J., and O'Kusky J.R. Insulin-like growth factor-I accelerates the cell cycle by decreasing G1 phase length and increases cell cycle reentry in the embryonic cerebral cortex. J. Neurosci. 24 (2004) 10201-10210
29. Hodge R.D., D'Ercole A.J., and O'Kusky J.R. Increased expression of insulin-like growth factor-I (IGF-I) during embryonic development produces neocortical overgrowth with differentially greater effects on specific cytoarchitectonic areas and cortical layers. Brain Res. Dev. Brain Res. 154 (2005) 227-237
30. Itasaki N., Bel-Vialar S., and Krumlauf R. 'Shocking' developments in chick embryology: electroporation and in ovo gene expression. Nat. Cell Biol. 1 (1999) E203-207
31. Jessell T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 1 (2000) 20-29
32. Lawlor M.A., Mora A., Ashby P.R., Williams M.R., Murray-Tait V., Malone L., Prescott A.R., Lucocq J.M., and Alessi D.R. Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 21 (2002) 3728-3738
33. Lopez-Carballo G., Moreno L., Masia S., Perez P., and Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 277 (2002) 25297-25304
34. Lunn J.S., Fishwick K.J., Halley P.A., and Storey K.G. A spatial and temporal map of FGF/Erk1/2 activity and response repertoires in the early chick embryo. Dev. Biol. 302 (2007) 536-552
35. Ma Q., Fode C., Guillemot F., and Anderson D.J. Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 13 (1999) 1717-1728
36. McManus E.J., Collins B.J., Ashby P.R., Prescott A.R., Murray-Tait V., Armit L.J., Arthur J.S., and Alessi D.R. The in vivo role of PtdIns(3,4,5)P(3) binding to PDK1 PH domain defined by knockin mutation. Embo J. 23 (2004) 2071-2082
37. McNeill H., Craig G.M., and Bateman J.M. Regulation of neurogenesis and epidermal growth factor receptor signaling by the insulin receptor/target of rapamycin pathway in Drosophila. Genetics 179 (2008) 843-853
38. Mizuguchi M., and Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 23 (2001) 508-515
39. Muise-Helmericks R.C., Grimes H.L., Bellacosa A., Malstrom S.E., Tsichlis P.N., and Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273 (1998) 29864-29872
40. Murakami M., Ichisaka T., Maeda M., Oshiro N., Hara K., Edenhofer F., Kiyama H., Yonezawa K., and Yamanaka S. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24 (2004) 6710-6718
41. Otaegi G., Yusta-Boyo M.J., Vergano-Vera E., Mendez-Gomez H.R., Carrera A.C., Abad J.L., Gonzalez M., de la Rosa E.J., Vicario-Abejon C., and de Pablo F. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells. J. Cell. Sci. 119 (2006) 2739-2748
42. Price S.R., and Briscoe J. The generation and diversification of spinal motor neurons: signals and responses. Mech. Dev. 121 (2004) 1103-1115
43. Rennebeck G., Kleymenova E.V., Anderson R., Yeung R.S., Artzt K., and Walker C.L. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15629-15634
44. Ribes V., Stutzmann F., Bianchetti L., Guillemot F., Dolle P., and Le Roux I. Combinatorial signalling controls Neurogenin2 expression at the onset of spinal neurogenesis. Dev. Biol. 321 (2008) 470-481
45. Scardigli R., Schuurmans C., Gradwohl G., and Guillemot F. Crossregulation between Neurogenin2 and pathways specifying neuronal identity in the spinal cord. Neuron 31 (2001) 203-217
46. Scardigli R., Baumer N., Gruss P., Guillemot F., and Le Roux I. Direct and concentration-dependent regulation of the proneural gene Neurogenin2 by Pax6. Development 130 (2003) 3269-3281
47. Sechrist J., and Bronner Fraser M. Birth and differentiation of reticular neurons in the chick hindbrain: ontogeny of the first neuronal population. Neuron 7 (1991) 947-963
48. Tschopp O., Yang Z.Z., Brodbeck D., Dummler B.A., Hemmings-Mieszczak M., Watanabe T., Michaelis T., Frahm J., and Hemmings B.A. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132 (2005) 2943-2954
49. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
50. Vojtek A.B., Taylor J., DeRuiter S.L., Yu J.Y., Figueroa C., Kwok R.P., and Turner D.L. Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol. Cell. Biol. 23 (2003) 4417-4427
51. Wakamatsu Y., and Weston J.A. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 124 (1997) 3449-3460
52. Wilcock A.C., Swedlow J.R., and Storey K.G. Mitotic spindle orientation distinguishes stem cell and terminal modes of neuron production in the early spinal cord. Development 134 (2007) 1943-1954
53. Wilkinson D.G., and Nieto M.A. Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. Methods Enzymol. 225 (1993) 361-373
54. Wu M.Y., Cully M., Andersen D., and Leevers S.J. Insulin delays the progression of Drosophila cells through G2/M by activating the dTOR/dRaptor complex. EMBO J. 26 (2007) 371-379
55. Yamanouchi H., Jay V., Rutka J.T., Takashima S., and Becker L.E. Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr. Neurol. 17 (1997) 49-53
56. Ye P., and D'Ercole A.J. Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J. Neurosci. Res. 83 (2006) 1-6